TY - JOUR
T1 - Human liver-specific very-long-chain acyl-coenzyme a synthetase
T2 - cDNA cloning and characterization of a second enzymatically active protein
AU - Steinberg, Steven J.
AU - Wang, Susan J.
AU - McGuinness, Martina C.
AU - Watkins, Paul A.
N1 - Funding Information:
We thank Dr. Catherine Thompson for COS-1 cells, Dr. Barbara Biery for the anti-myc antibody, Dr. Stephen Gould for the pNmyc vector, Dr. Joel Avigan for methyl pristanate, Dr. HeMing Wei for glyceraldehyde-3-phosphate dehydrogenase oligonucleotide primers and human genomic DNA, and Dr. Kirby Smith, Dr. Hugo Moser, and Dr. Stephanie Mihalik for many thoughtful discussions. This work was supported by NIH Grants NS10533, NS37355, HD10981, and DK51149.
PY - 1999/9
Y1 - 1999/9
N2 - Activation of fatty acids, catalyzed by acyl-coenzyme A (acyl-CoA) synthetases, is required for their subsequent metabolism. Peroxisomes and microsomes contain very-long-chain acyl-CoA synthetases (VLCSs) capable of activating fatty acids with a chain length of 22 or more carbons. Decreased peroxisomal VLCS activity is, in part, responsible for the biochemical pathology in X-linked adrenoleukodystrophy (X-ALD), illustrating the importance of VLCSs in cellular fatty acid homeostasis. We previously cloned two human genes encoding proteins homologous to rat peroxisomal VLCS; one (hVLCS) is the human ortholog to the rat VLCS gene and another (hVLCS-H1) encodes a related heart-specific protein. Here, we report the cloning of a third gene (hVLCS-H2) and characterization of its protein product. The hVLCS- H2 gene is located on human chromosome 19 and encodes a 690-amino-acid protein. The amino acid sequence of hVLCS-H2 is 4445% identical and 67-69% similar to those of both hVLCS and hVLCS-H1. COS-1 cells transiently overexpressing hVLCS-H2 activated the very-long-chain fatty acid lignocerate (C24:0) at a rate > 1.5-fold higher than that of nontransfected cells (P < 0.002). The hVLCS-H2-dependent activation of long- and branched-chain fatty acids following transient transfection was less striking. However, hVLCS-H2- dependent acyl-CoA synthetase activity with long-and very-long-chain fatty acid substrates was detected in COS-1 cells stably expressing hVLCS-H2. For all substrates tested (C18:0, C20:0, C24:0, C26:0), the hVLCS-H2 catalyzed activity was significantly increased (P < 0.01 to P < 0.0001). By both Northern analysis and reverse transcription polymerase chain reaction, hVLCS- H2 is expressed primarily in liver. Indirect immunofluorescence of COS-1 cells or human hepatoma-derived HepG2 cells expressing epitope-tagged hVLCS- H2 revealed that the protein was associated with the endoplasmic reticulum but not with peroxisomes. Thus, the primary role of hVLCS-H2 is likely to be in fatty acid elongation or complex lipid synthesis rather than in degradation.
AB - Activation of fatty acids, catalyzed by acyl-coenzyme A (acyl-CoA) synthetases, is required for their subsequent metabolism. Peroxisomes and microsomes contain very-long-chain acyl-CoA synthetases (VLCSs) capable of activating fatty acids with a chain length of 22 or more carbons. Decreased peroxisomal VLCS activity is, in part, responsible for the biochemical pathology in X-linked adrenoleukodystrophy (X-ALD), illustrating the importance of VLCSs in cellular fatty acid homeostasis. We previously cloned two human genes encoding proteins homologous to rat peroxisomal VLCS; one (hVLCS) is the human ortholog to the rat VLCS gene and another (hVLCS-H1) encodes a related heart-specific protein. Here, we report the cloning of a third gene (hVLCS-H2) and characterization of its protein product. The hVLCS- H2 gene is located on human chromosome 19 and encodes a 690-amino-acid protein. The amino acid sequence of hVLCS-H2 is 4445% identical and 67-69% similar to those of both hVLCS and hVLCS-H1. COS-1 cells transiently overexpressing hVLCS-H2 activated the very-long-chain fatty acid lignocerate (C24:0) at a rate > 1.5-fold higher than that of nontransfected cells (P < 0.002). The hVLCS-H2-dependent activation of long- and branched-chain fatty acids following transient transfection was less striking. However, hVLCS-H2- dependent acyl-CoA synthetase activity with long-and very-long-chain fatty acid substrates was detected in COS-1 cells stably expressing hVLCS-H2. For all substrates tested (C18:0, C20:0, C24:0, C26:0), the hVLCS-H2 catalyzed activity was significantly increased (P < 0.01 to P < 0.0001). By both Northern analysis and reverse transcription polymerase chain reaction, hVLCS- H2 is expressed primarily in liver. Indirect immunofluorescence of COS-1 cells or human hepatoma-derived HepG2 cells expressing epitope-tagged hVLCS- H2 revealed that the protein was associated with the endoplasmic reticulum but not with peroxisomes. Thus, the primary role of hVLCS-H2 is likely to be in fatty acid elongation or complex lipid synthesis rather than in degradation.
KW - Acyl-coenzyme A synthetase
KW - Human liver
KW - Very-long-chain fatty acids
KW - X- linked adrenoleukodystrophy
UR - http://www.scopus.com/inward/record.url?scp=0032887065&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032887065&partnerID=8YFLogxK
U2 - 10.1006/mgme.1999.2883
DO - 10.1006/mgme.1999.2883
M3 - Article
C2 - 10479480
AN - SCOPUS:0032887065
SN - 1096-7192
VL - 68
SP - 32
EP - 42
JO - Molecular genetics and metabolism
JF - Molecular genetics and metabolism
IS - 1
ER -